Wegovy Pill Side Effects: What to Expect Week by Week (2026)

Oral Wegovy (semaglutide 25 mg tablet) became the first oral GLP-1 receptor agonist approved for chronic weight management. While the convenience of a pill over a weekly injection appeals to many patients, the side effect profile is something every new user should understand before starting treatment. Data from the OASIS 4 clinical trial — the pivotal study that led to FDA approval — gives us a clear picture of what to expect, when symptoms peak, and how to manage them.

Common GI Side Effects From OASIS 4

Gastrointestinal side effects are the most frequently reported adverse events with oral Wegovy. The OASIS 4 trial enrolled over 2,000 adults with obesity or overweight and documented the following incidence rates at the 25 mg maintenance dose:

Side Effect	Incidence (25 mg)	Placebo
Nausea	25–30%	6–8%
Diarrhea	15–20%	5–7%
Vomiting	10–15%	2–3%
Constipation	10–15%	3–4%
Abdominal pain	5–8%	3%

Most side effects were rated as mild to moderate in severity. In OASIS 4, approximately 6% of participants discontinued treatment due to GI adverse events — compared to about 1% in the placebo group.

Dosing and Timing Requirements

Oral Wegovy must be taken on an empty stomach with no more than 4 oz (120 mL) of plain water, at least 30 minutes before any food, drink, or other medications. This strict protocol ensures the absorption enhancer (SNAC) can function properly. Taking the tablet with food, coffee, or too much liquid can reduce drug absorption by up to 40%, potentially worsening side effects without delivering the full therapeutic dose.

Week-by-Week Side Effect Timeline

Side effects are most pronounced during the 4-month titration phase as your body adjusts to increasing doses (1.5 mg → 4 mg → 9 mg → 25 mg). Here is what to expect:

• Weeks 1–2 (1.5 mg): Mild nausea and occasional bloating are common. Most patients tolerate this starting dose well. Appetite suppression begins but is modest.
• Weeks 3–4 (end of 1.5 mg): Nausea may peak briefly as your body adjusts. Some patients report mild headaches and fatigue.
• Weeks 5–8 (4 mg): The first dose increase often triggers a temporary return of nausea. Diarrhea may appear in 10–15% of patients. Appetite suppression becomes more noticeable.
• Weeks 9–12 (9 mg): GI symptoms begin to stabilize for most patients. Constipation may emerge and persist. Vomiting is less common at this stage than during the initial weeks.
• Month 4+ (25 mg maintenance): Most patients report significantly reduced side effects. Occasional nausea may persist in 5–10% of users, but it is typically manageable. Weight loss accelerates at this dose.

Tips for Managing Nausea and GI Discomfort

Evidence-based strategies to reduce nausea and improve tolerability during titration:

• Eat small, frequent meals — 5–6 small meals rather than 3 large ones reduce gastric distension and nausea triggers.
• Choose bland foods — toast, rice, bananas, plain chicken, and crackers are easier on the stomach during the first weeks.
• Use ginger — ginger tea, ginger supplements (250 mg four times daily), or ginger candies have antiemetic properties supported by clinical evidence.
• Stay hydrated — sip water or electrolyte drinks throughout the day. Dehydration worsens nausea and can compound diarrhea-related fluid loss.
• Avoid fatty, spicy, or fried foods — these slow gastric emptying further and can amplify GI symptoms.
• Take the tablet at the same time daily — consistency helps your body adapt and reduces symptom variability.
• Ask about anti-nausea medication — your provider may prescribe ondansetron (Zofran) for severe nausea during the first 2–4 weeks of titration.

Serious Risks and Boxed Warning

Wegovy carries a boxed warning — the FDA's most serious warning — for thyroid C-cell tumors. In rodent studies, semaglutide caused dose-dependent thyroid C-cell tumors. While the relevance to humans is unknown, Wegovy is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Other serious risks include:

• Pancreatitis: Severe, persistent abdominal pain radiating to the back. Discontinue Wegovy immediately if suspected.
• Gallbladder disease: Cholelithiasis (gallstones) and cholecystitis have been reported. Watch for right upper quadrant pain, jaundice, or fever.
• Acute kidney injury: Dehydration from nausea, vomiting, or diarrhea can trigger kidney problems. Monitor urine output.
• Suicidal ideation: The FDA is monitoring reports of mood changes and suicidal thoughts with GLP-1 medications. Report any changes in mood to your provider.

When to Call Your Doctor

Contact your healthcare provider immediately if you experience:

• A lump or swelling in your neck (possible thyroid tumor)
• Severe abdominal pain that does not resolve within 24 hours
• Persistent vomiting that prevents you from keeping fluids down
• Signs of dehydration: dark urine, dizziness, rapid heartbeat
• Yellowing of the skin or eyes (jaundice)
• Changes in vision
• Any signs of allergic reaction: rash, swelling of the face or throat, difficulty breathing

Oral vs Injectable Wegovy: Side Effect Comparison

Both formulations contain semaglutide and share a similar side effect profile. However, the OASIS 4 data for the oral form shows a slightly higher incidence of nausea (25–30%) compared to the STEP 1 trial for injectable Wegovy (~20–25%). This is likely because the oral tablet makes direct contact with the GI tract during absorption. Diarrhea and vomiting rates are comparable between formulations. Injection site reactions (redness, itching, bruising) only occur with the injectable form and are not a concern with the pill.

For a full comparison, see our guide on Wegovy pill vs injection.

Medical Disclaimer

This content is for informational purposes only and does not constitute medical advice. Wegovy is a prescription medication — always consult your healthcare provider before starting, stopping, or changing your treatment. Side effects may vary based on individual health status, dosage, and concomitant medications. If you experience any serious side effects, seek immediate medical attention.